US56600D1072
© BusinessWire
09.02.2026
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
News Preview
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same d...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
News Preview
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November.
On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
News Preview
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates.
Quarterly Results:
Revenue of $41.6 million, Net loss of $(45.1) milli...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
22.10.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
News Preview
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. P...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
11.08.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
News Preview
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.07.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
News Preview
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results after the market close on Monday, August 11, 2025, and will host a conference cal...
Themefolio
Profiler
Peergroup
© BusinessWire
26.07.2025
MRVI
LISTED
NASDAQ
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Maravai LifeSciences Holdings, Inc. (NasdaqGS: MRVI).
On February 25, 2025, the Company disclosed that it would delay filing its annual report on Form 10-K for t...
Themefolio
Profiler
Peergroup
© BusinessWire
28.06.2025
MRVI
LISTED
NASDAQ
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Maravai LifeSciences Holdings, Inc. (NasdaqGS: MRVI).
On February 25, 2025, the Company disclosed that it would delay filing its annual report on Form 10-K for t...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
News Preview
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Quantoom Biosciences, a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. Under the agreement, Quantoom will have access...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2025
MRVI
LISTED
NASDAQ
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
News Preview
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth...
Themefolio
Profiler
Peergroup
© BusinessWire
20.05.2025
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
News Preview
TriLink BioTechnologies® (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research — starting with a significant donation to top academic labs across the U.S. and Europe.
The donation commemorates the launch of TriLink’s first mRNA synthesis kit featuring CleanCap® capping technology, an all-in-one kit wit...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
News Preview
Today, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization devoted to and the discovery, development and delivery of vaccines for global health signed a Memorandum of Under...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.05.2025
MRVI
LISTED
NASDAQ
Maravai Lifesciences Reports First Quarter 2025 Financial Results
News Preview
SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2025, together with other business updates....
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
MRVI
LISTED
NASDAQ
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
MRVI
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) and reminds investors of the May 5, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
27.04.2025
MRVI
LISTED
NASDAQ
MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies...
Themefolio
Profiler
Peergroup
© BusinessWire
17.04.2025
MRVI
LISTED
NASDAQ
Kirby McInerney LLP Urges Investors in Maravai Lifesciences Holdings, Inc. to Inquire About Their Rights in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
MRVI
LISTED
NASDAQ
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) and reminds investors of the May 5, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
MRVI
LISTED
NASDAQ
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendant...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.03.2025
MRVI
LISTED
NASDAQ
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Schedules Conference Call for Thursday, March 20, 2025 Schedules Conference Call for Thursday, March 20, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
12.03.2025
MRVI
LISTED
NASDAQ
MRVI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), have until May 5, 2025 to seek appointment as lead plaintiff of the Maravai class action lawsuit. Capti...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
MRVI
LISTED
NASDAQ
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violatio...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
MRVI
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”). Maravai investors have until May 4, 2025 to file a lead p...
Themefolio
Profiler
Peergroup
© BusinessWire
08.03.2025
MRVI
LISTED
NASDAQ
MRVI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), have until May 5, 2025 to seek appointment as lead plaintiff of the Maravai class action lawsuit. Capti...
Themefolio
Profiler
Peergroup
© BusinessWire
07.03.2025
MRVI
LISTED
NASDAQ
Deadline Approaching: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming May 5, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).
IF YOU...
Themefolio
Profiler
Peergroup
© BusinessWire
07.03.2025
MRVI
LISTED
NASDAQ
MRVI Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© BusinessWire
06.03.2025
MRVI
LISTED
NASDAQ
Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming May 5, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, inclusiv...
Themefolio
Profiler
Peergroup
© BusinessWire
06.03.2025
MRVI
LISTED
NASDAQ
MRVI ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Maravai Lifesciences Holdings, Inc. Investors
News Preview
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 2025 (“the...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
MRVI
LISTED
NASDAQ
Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies, diagno...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
MRVI
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”). Maravai investors have until May 5, 2025 to file a lead pla...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
MRVI
LISTED
NASDAQ
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Comm...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
MRVI
LISTED
NASDAQ
MRVI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc.
News Preview
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Nelson v. Maravai LifeSciences Holdings, Inc., et al., Case No. 25-cv-00499, on behalf of persons and entities that purchased or otherwise acquired Maravai LifeSciences Holdings,...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
MRVI
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) and reminds investors of the May 5, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
MRVI
LISTED
NASDAQ
MRVI Class Action Notice: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Maravai LifeSciences Holdings, Inc. Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Nelson v. Maravai LifeSciences Holdings, Inc., et al., Case No. 25-cv-00499, on behalf of persons and entities that purchased or otherwise acquired Maravai LifeSciences H...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
MRVI
LISTED
NASDAQ
MRVI INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Maravai LifeSciences Holdings, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
News Preview
Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) focused on whether the company and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
If you have i...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
MRVI
LISTED
NASDAQ
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Securities Fraud Investigation: Investors Urged to Contact Award-Winning Firm, Gibbs Law Group LLP
News Preview
Shares of Maravai LifeSciences Holdings, Inc. (“Maravai LifeSciences”) plunged over 21% in intraday trading on Tuesday, February 25, 2025, after the company disclosed it would be delaying its 2024 earnings release. The company delayed the earning release and investor call, stating that it needs additional time to complete an assessment of disclosu...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI), CONTACT THE LAW OFFICES...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
MRVI
LISTED
NASDAQ
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI), CLICK HERE TO INQUIRE A...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.02.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
News Preview
SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that it is postponing its previously announced earnings release and call scheduled for February 25, 2025. It also announced that i...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
News Preview
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced acquisition of Officinae Bio’s DNA and RNA business. This acquisition combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and Tri...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
News Preview
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Aldevron, a leading, global Contract Development and Manufacturing Organization (CDMO) providing high-quality plasmid DNA, RNA, and proteins for r...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
News Preview
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, to expand availabilit...
Themefolio
Profiler
Peergroup
© BusinessWire
28.01.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
News Preview
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property and relevant assets from Molecular Assemblies (MAI). The acquisition will expand Maravai and TriLink BioTechnologies' ability to enable customers to devel...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2025
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
News Preview
Announces Earnings Release Date Announces Earnings Release Date...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.12.2024
MRVI
LISTED
NASDAQ
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
News Preview
Carl Hull to Retire as Executive Chairman Carl Hull to Retire as Executive Chairman...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2024
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
News Preview
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November....
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2024
MRVI
LISTED
NASDAQ
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
News Preview
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA production. The new product reduces dsRNA by up to 85%, helping to develop safer, more potent mRNA therapeutics.
CleanScribe RNA Polymerase is a novel DN...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2024
MRVI
LISTED
NASDAQ
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
News Preview
Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have leveraged state-of-the-art technologies and reagents to develop an assay with unparalleled sensitivity and specificity to hel...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2024
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
News Preview
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in August and September....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.07.2024
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
News Preview
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on Wednesday, August 7, 2024, and will host a conference...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
